Apoe
M. musculus
apolipoprotein E
What the model saw
Gene: Apoe Organism: Mus musculus Known functions: apolipoprotein E. amyloid-beta binding. antioxidant activity. cholesterol transfer activity. enzyme binding. heparan sulfate proteoglycan binding. heparin binding. hydroxyapatite binding. identical protein binding. lipid binding. lipid carrier activity. lipoprotein particle binding. low-density lipoprotein particle receptor binding. metal chelating activity. phosphatidylcholine-sterol O-acyltransferase activator activity. phospholipid binding. protein binding. protein dimerization activity. protein homodimerization activity. protein-containing complex binding. receptor ligand activity. signaling receptor binding. tau protein binding. very-low-density lipoprotein particle receptor binding.
View unredacted entry
apolipoprotein E. amyloid-beta binding. antioxidant activity. cholesterol transfer activity. enzyme binding. heparan sulfate proteoglycan binding. heparin binding. hydroxyapatite binding. identical protein binding. lipid binding. lipid carrier activity. lipoprotein particle binding. low-density lipoprotein particle receptor binding. metal chelating activity. phosphatidylcholine-sterol O-acyltransferase activator activity. phospholipid binding. protein binding. protein dimerization activity. protein homodimerization activity. protein-containing complex binding. receptor ligand activity. signaling receptor binding. tau protein binding. very-low-density lipoprotein particle receptor binding.
Solver output
ApoE is the primary lipid transport protein in the brain and periphery, mediating cholesterol redistribution via LDL receptor and VLDL receptor binding. Certain ApoE isoforms (particularly ApoE4 in humans, with mouse ApoE being functionally analogous) impair lipid homeostasis, promote neuroinflammation, and facilitate amyloid-beta aggregation through direct amyloid-beta binding and tau protein binding interactions, accelerating neurodegeneration. ApoE's role as a receptor ligand for LDL/VLDL receptors influences atherosclerotic plaque formation and cardiovascular risk, both of which are anti-longevity. Its tau protein binding activity further links it to tauopathy and neurodegeneration pathways. While ApoE has some antioxidant and metal-chelating activities that could be protective, the dominant functional annotations—amyloid-beta binding, tau binding, and pro-atherogenic lipoprotein metabolism—are strongly associated with age-related disease acceleration rather than longevity promotion.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted anti_longevity with 0.72 confidence, but the ground truth is pro_longevity. The model's reasoning conflates human ApoE4 isoform biology with mouse ApoE, which is a significant error. In mice, ApoE knockout studies show that loss of ApoE leads to hypercholesterolemia and accelerated atherosclerosis, meaning ApoE is protective (pro-longevity) in mice. The model incorrectly applied human ApoE4 disease associations to mouse ApoE and focused on amyloid-beta and tau pathology pathways that are more relevant to human Alzheimer's disease risk rather than mouse longevity phenotypes. The antioxidant and lipid homeostasis functions of ApoE in mice are actually protective. The model's mechanistic reasoning is flawed in its application to the mouse context.
Raw API responses
solver
{
"reasoning": "ApoE is the primary lipid transport protein in the brain and periphery, mediating cholesterol redistribution via LDL receptor and VLDL receptor binding. Certain ApoE isoforms (particularly ApoE4 in humans, with mouse ApoE being functionally analogous) impair lipid homeostasis, promote neuroinflammation, and facilitate amyloid-beta aggregation through direct amyloid-beta binding and tau protein binding interactions, accelerating neurodegeneration. ApoE's role as a receptor ligand for LDL/VLDL receptors influences atherosclerotic plaque formation and cardiovascular risk, both of which are anti-longevity. Its tau protein binding activity further links it to tauopathy and neurodegeneration pathways. While ApoE has some antioxidant and metal-chelating activities that could be protective, the dominant functional annotations—amyloid-beta binding, tau binding, and pro-atherogenic lipoprotein metabolism—are strongly associated with age-related disease acceleration rather than longevity promotion.",
"confidence": 0.72,
"key_pathways": [
"amyloid-beta aggregation and neurodegeneration",
"LDL/VLDL receptor-mediated lipoprotein metabolism and atherosclerosis",
"tau protein pathology"
],
"mechanism_class": "chronic_inflammation",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model predicted anti_longevity with 0.72 confidence, but the ground truth is pro_longevity. The model's reasoning conflates human ApoE4 isoform biology with mouse ApoE, which is a significant error. In mice, ApoE knockout studies show that loss of ApoE leads to hypercholesterolemia and accelerated atherosclerosis, meaning ApoE is protective (pro-longevity) in mice. The model incorrectly applied human ApoE4 disease associations to mouse ApoE and focused on amyloid-beta and tau pathology pathways that are more relevant to human Alzheimer's disease risk rather than mouse longevity phenotypes. The antioxidant and lipid homeostasis functions of ApoE in mice are actually protective. The model's mechanistic reasoning is flawed in its application to the mouse context.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}